ASD
49
8
11
22
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 49 trials
100.0%
+13.5% vs benchmark
4%
2 trials in Phase 3/4
36%
8 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (49)
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Comprehensive Toileting Program
Spironolactone Improved Children With Gene Mutations Related to NCOR
The Effects of Tailored Judo Training and Nutritional Counseling on Physical Fitness and Body Composition in Children With Autism: A Study Including Blood Morphology and Genetic Analysis
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
Differences in N-CAD Concentration and Brain Function Between Children With ASD and TD
A Phase 2A Trial of MM402 for Autism Spectrum Disorder
Omega-3, Autism Spectrum Disorder (ASD)
Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With Autism
GENES AND AUTISM - IPSC
Testing Scalable Caregiver Interventions for Autism
Posture, Hand Functions and Sensory Processing Skills on Nutrition
Intranasal Vasopressin Treatment in Children With Autism
Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits
Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
Electrocardiographic and Electrophysiologic Changes After Percutaneous Closure of Atrial Septal Defect
A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations